Navigation Links
Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments
Date:5/17/2010

f this year.  We are also currently enrolling patients in our confirmatory Phase 3 clinical trial of orBec® in the treatment of acute gastrointestinal GVHD, which is targeted to complete in the first half of next year.  orBec® is poised to potentially be the first FDA-approved therapy for this unmet medical need. We are optimistic that we will be able to continue our positive momentum and growth into 2011."

Soligenix's 2010 Highlights:  

  • On May 12, 2010, Soligenix announced that patient enrollment was completed in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of orBec® for the prevention of acute Graft-versus-Host disease after allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning regimens.  The study is being supported, in large part, by an NIH grant.

  • On May 10, 2010, Soligenix announced that the European Patent Office granted patent EP 1392321 "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids."  The new patent's main claims cover the use of topically active corticosteroids in orally administered dosage forms that act concurrently in the upper and lower gastrointestinal tract.

  • On February 17, 2010, Soligenix announced that it received a Hong Kong patent that addresses its Lipid Polymer Micelle (LPM™) technology for the improved oral delivery of drugs. The issued Hong Kong patent, HK 1071054, entitled "Stabilized Reverse Micelle Compositions and Uses Thereof," covers lipid
    '/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial
2. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
3. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
4. Soligenix Reports Third Quarter 2009 Financial Results
5. Soligenix to Present at 8th Annual BIO Investor Forum
6. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
7. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
8. Sinovac Reports Unaudited First Quarter 2010 Financial Results
9. Microbix Reports a Record Increase in Worldwide Sales for 2nd Quarter 2010
10. Transdel Pharmaceuticals Reports First Quarter 2010 Results
11. Aeterna Zentaris Reports First Quarter 2010 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Israel , July 23, 2014 ... a portfolio company of Trendlines Agtech , ... of Israel,s leading agricultural ... , Valentis,s technology combines nanocrystalline cellulose ... pulp waste, with additional nanoparticles to produce highly ...
(Date:7/23/2014)... 2014 Shire plc (LSE: ... specialty biopharmaceutical company, and ArmaGen, a US privately ... and collaboration agreement for AGT-182, an investigational enzyme ... both the central nervous system (CNS) and somatic ... This collaboration strengthens Shire,s rare disease pipeline of ...
(Date:7/23/2014)... California (PRWEB) July 23, 2014 With the ... in HD resolution for more than 15 minutes, Fastec Imaging ... the world of high speed imaging. “Finally, a high speed ... camera we use in our everyday lives.” proclaims Matt Kearney, ... Fastec has always been to demystify and simplify the traditionally ...
(Date:7/23/2014)... 2014 Astra Nova Training ... consultancy and pharma training services, and the ... , a non-profit integrating the expertise and investments ... a global system for clinical trials, are pleased ... the expertise of industry professionals through improved and ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... Mass., Sept. 17 Interleukin Genetics,(Amex: ILI ... Scientific,Officer, Kenneth Kornman, DDS, PhD, will present at ... Alexandria, VA. The conference will,focus on innovative methods ... Among a group of presenters that includes industry ...
... Bio IV NVS Strategic Fund L.P. invests $10 ... Radius Health ("Radius"),announced today that it has ... to,obtain an exclusive worldwide license (except Japan) to ... drug,candidate. BA058 is a proprietary analog of hPTHrP ...
... Medical School researchers have successfully synthesized a DNA-based memory ... step forward in the emerging field of synthetic biology. ... DNA, researchers in the lab of Professor Pamela Silver, ... Systems Biology, not only reconstructed the dynamics of memory, ...
Cached Biology Technology:Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference 2Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference 3Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis 2Scientists synthesize memory in yeast cells 2Scientists synthesize memory in yeast cells 3
(Date:7/23/2014)... Springer will publish the International Journal of Fuzzy ... the Taiwan Fuzzy Systems Association (TFSA). The cooperation will ... the area of fuzzy research., The International Journal ... papers that deal with the theory, design and application ... extension theory systems ranging from hardware to software. Launched ...
(Date:7/23/2014)... , July 23, 2014   MedNet Solutions ... in clinical study management systems, is pleased to ... proven life sciences industry executive with over 25 ... Officer (COO).  Clareece will be responsible for MedNet,s ... operational efficiency and quality product/service delivery.  ...
(Date:7/23/2014)... the principal bacteria that cause dental caries, has ... time, possibly coinciding with dietary change linked to ... in a study by researchers from the Universitat ... de Genmica para la Biodiversidad (National Laboratory of ... first time, have sequenced genetic material from this ...
Breaking Biology News(10 mins):MedNet Appoints Clareece West As Chief Operating Officer 2Ancient genetic material from caries bacterium obtained for the first time 2
... For the first time, researchers at the University of ... to tap into nitrogen found in rocks, boosting the trees, ... the atmosphere. Given that carbon dioxide is the most ... how rapidly the earth will warm in the future, the ...
... CREEK, Calif.Understanding the flow and processing of carbon in ... surface, is central to understanding global climate cycles, with ... below the ocean surface exists a "twilight zone" where ... this, it is known that microbes resident at these ...
... Examining brain damage that occurs when fetuses in the ... Institute have discovered that damage does not occur randomly but ... fatty molecule called LPA, acting through a receptor that transfers ... mice suggests that LPA may also be linked to the ...
Cached Biology News:Bedrock nitrogen may help forests buffer climate change, study finds 2Bedrock nitrogen may help forests buffer climate change, study finds 3Up from the depths: How bacteria capture carbon in the 'twilight zone' 2Discovery suggests way to block fetal brain damage produced by oxygen deprivation 2Discovery suggests way to block fetal brain damage produced by oxygen deprivation 3
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Normal serum collected from healthy Kunming mice....
Request Info...
Biology Products: